dipyridamole has been researched along with Peripheral Nerve Diseases in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connor, SJ | 1 |
| Nukada, H | 1 |
| Sandner-Kiesling, A | 1 |
| Li, X | 1 |
| Eisenach, JC | 1 |
2 other studies available for dipyridamole and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Vasodilating effect of dipyridamole on rat endoneurial vessels: morphometric study.
Topics: Animals; Dipyridamole; Ischemia; Male; Peripheral Nerves; Peripheral Nervous System Diseases; Random | 1993 |
Morphine-induced spinal release of adenosine is reduced in neuropathic rats.
Topics: Adenosine; Analgesics, Opioid; Animals; Behavior, Animal; Dipyridamole; Dose-Response Relationship, | 2001 |